Yao, J., Xi, W., Zhu, Y., Wang, H., Hu, X., & Guo, J. (2018). Checkpoint molecule PD-1-assisted CD8(+) T lymphocyte count in tumor microenvironment predicts overall survival of patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors. Cancer Manag Res.

Yao, Jiaxi, Wei Xi, Yanjun Zhu, Hang Wang, Xiaoyi Hu, و Jianming Guo. "Checkpoint Molecule PD-1-assisted CD8(+) T Lymphocyte Count in Tumor Microenvironment Predicts Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors." Cancer Manag Res 2018.

Yao, Jiaxi, et al. "Checkpoint Molecule PD-1-assisted CD8(+) T Lymphocyte Count in Tumor Microenvironment Predicts Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors." Cancer Manag Res 2018.